Nutri Pharmaceuticals Research Stock Performance
| NRPR Stock | USD 0.05 0.00 0.00% |
Nutri Pharmaceuticals holds a performance score of 11 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 2.13, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nutri Pharmaceuticals will likely underperform. Use Nutri Pharmaceuticals risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and day median price , to analyze future returns on Nutri Pharmaceuticals.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Nutri Pharmaceuticals Research are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile basic indicators, Nutri Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Nutri |
Nutri Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 2.10 in Nutri Pharmaceuticals Research on October 1, 2025 and sell it today you would earn a total of 2.60 from holding Nutri Pharmaceuticals Research or generate 123.81% return on investment over 90 days. Nutri Pharmaceuticals Research is currently generating 1.8297% in daily expected returns and assumes 12.2557% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Nutri, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nutri Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nutri Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nutri Pharmaceuticals Research, and traders can use it to determine the average amount a Nutri Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1493
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | NRPR | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Nutri Pharmaceuticals is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nutri Pharmaceuticals by adding it to a well-diversified portfolio.
Nutri Pharmaceuticals Fundamentals Growth
Nutri Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nutri Pharmaceuticals, and Nutri Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nutri Pink Sheet performance.
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.38) % | |||
| Current Valuation | 67.46 K | |||
| Shares Outstanding | 938.62 K | |||
| Price To Earning | 0.07 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 1.21 M | |||
| EBITDA | (423.34 K) | |||
| Cash And Equivalents | 90.07 K | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 125.86 K | |||
| Debt To Equity | 0.53 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | 22.68 K | |||
| Earnings Per Share | (0.65) X | |||
About Nutri Pharmaceuticals Performance
Assessing Nutri Pharmaceuticals' fundamental ratios provides investors with valuable insights into Nutri Pharmaceuticals' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Nutri Pharmaceuticals is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Nutri Pharmaceuticals Research, Inc. engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. The company uses its oil to powder products as ingredients in finished goods, such as food, pet food, nutraceuticals or vitamin supplements, cosmetics, and organic household products. Nutri Pharms operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Nutri Pharmaceuticals performance evaluation
Checking the ongoing alerts about Nutri Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nutri Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nutri Pharmaceuticals is way too risky over 90 days horizon | |
| Nutri Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Nutri Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Nutri Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Nutri Pharmaceuticals Research currently holds 125.86 K in liabilities with Debt to Equity (D/E) ratio of 0.53, which is about average as compared to similar companies. Nutri Pharmaceuticals has a current ratio of 0.71, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nutri Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Nutri Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nutri Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nutri to invest in growth at high rates of return. When we think about Nutri Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.21 M. Net Loss for the year was (467.59 K) with profit before overhead, payroll, taxes, and interest of 18.95 K. |
- Analyzing Nutri Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nutri Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Nutri Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nutri Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nutri Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nutri Pharmaceuticals' pink sheet. These opinions can provide insight into Nutri Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Nutri Pink Sheet Analysis
When running Nutri Pharmaceuticals' price analysis, check to measure Nutri Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutri Pharmaceuticals is operating at the current time. Most of Nutri Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nutri Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutri Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nutri Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.